CGS vs MVP

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

58MEDIUM

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

Score Breakdown

CGS MVP
Technical
47
37
Catalyst
53
54
Sentiment
50
50
Fundamental
96
95
Momentum
79
49
Risk Gate
50
50

Key Metrics

CGS Metric MVP
$489.3MMarket Cap$45.6M
397KAvg Volume (20d)136K
+0.1%Short InterestN/A
$3.01052-Week High$0.765
$1.55052-Week Low$0.365
-3.5%Daily Change+0.0%
$2.780Reference Price$0.405
+22.5%ROE-0.8%
+19.2%Profit Margin-1.1%

Active Signals

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

Ask Scout AI to compare CGS and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs CMP →AHC vs ARX →AHC vs EYE →ARX vs CMP →CMP vs EYE →
CGS Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).